Literature DB >> 7830567

The RTX haemolysins ApxI and ApxII are major virulence factors of the swine pathogen Actinobacillus pleuropneumoniae: evidence from mutational analysis.

R I Tascón1, J A Vázquez-Boland, C B Gutiérrez-Martín, I Rodríguez-Barbosa, E F Rodríguez-Ferri.   

Abstract

The involvement of the RTX haemolysins (ApxI and ApxII) of the swine pathogen Actinobacillus pleuropneumoniae in virulence was investigated using haemolysin-deficient mutants constructed by a mini-Tn10 mutagenesis procedure. Two types of haemolysin mutant with single insertions of the transposon were obtained from a serotype 1 strain producing both ApxI and ApxII. One presented a complete loss of haemolytic activity because of the absence of ApxI and ApxII production. The other displayed weaker haemolysis than the wild type and produced only ApxII. The chromosomal regions flanking mini-Tn10 were cloned and sequenced. In the non-haemolytic mutant, the transposon had inserted in apxIB, a gene involved in the exportation of ApxI and ApxII toxins. The weakly haemolytic mutant resulted from the disruption of the structural gene for ApxI. Both mutations in the apxI operon were associated with a significant loss of virulence for mice and pigs, demonstrating that haemolysins are involved in A. pleuropneumoniae pathogenicity. The non-haemolytic mutant was apathogenic and the weakly haemolytic mutant retained some virulence for pigs, suggesting that both ApxI and ApxII are needed for full virulence.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7830567     DOI: 10.1111/j.1365-2958.1994.tb01282.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  19 in total

1.  The N-terminal domain of RTX toxin ApxI of Actinobacillus pleuropneumoniae elicits protective immunity in mice.

Authors:  J N Seah; J Frey; J Kwang
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

2.  Endobronchial inoculation with Apx toxins of Actinobacillus pleuropneumoniae leads to pleuropneumonia in pigs.

Authors:  E M Kamp; N Stockhofe-Zurwieden; L A van Leengoed; M A Smits
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

Review 3.  Role of pore-forming toxins in bacterial infectious diseases.

Authors:  Ferdinand C O Los; Tara M Randis; Raffi V Aroian; Adam J Ratner
Journal:  Microbiol Mol Biol Rev       Date:  2013-06       Impact factor: 11.056

4.  Cytotoxic activities of Leptospira interrogans hemolysin SphH as a pore-forming protein on mammalian cells.

Authors:  Seoung Hoon Lee; Sangduk Kim; Seung Chul Park; Min Ja Kim
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

5.  Channel-forming activity and channel size of the RTX toxins ApxI, ApxII, and ApxIII of Actinobacillus pleuropneumoniae.

Authors:  E Maier; N Reinhard; R Benz; J Frey
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

6.  Vaccination and protection of pigs against pleuropneumonia with a vaccine strain of Actinobacillus pleuropneumoniae produced by site-specific mutagenesis of the ApxII operon.

Authors:  C T Prideaux; C Lenghaus; J Krywult; A L Hodgson
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

7.  Predicting genetic traits and epitope analysis of apxIVA in Actinobacillus pleuropneumoniae.

Authors:  Min-Kyoung Shin; Seung-Bin Cha; Won-Jung Lee; Han Sang Yoo
Journal:  J Microbiol       Date:  2011-06-30       Impact factor: 3.422

8.  Branched-chain amino acids are required for the survival and virulence of Actinobacillus pleuropneumoniae in swine.

Authors:  Sargurunathan Subashchandrabose; Rhiannon M LeVeque; Trevor K Wagner; Roy N Kirkwood; Matti Kiupel; Martha H Mulks
Journal:  Infect Immun       Date:  2009-08-24       Impact factor: 3.441

9.  Association of Actinobacillus pleuropneumoniae capsular polysaccharide with virulence in pigs.

Authors:  Aloka B Bandara; Mark L Lawrence; Hugo P Veit; Thomas J Inzana
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

10.  GtxA from Gallibacterium anatis, a cytolytic RTX-toxin with a novel domain organisation.

Authors:  Bodil Marie Kristensen; Dorte Frees; Anders Miki Bojesen
Journal:  Vet Res       Date:  2009-12-04       Impact factor: 3.683

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.